Gaelic Laboratories Expands to the Middle East with UAE Subsidiary

• Gaelic Laboratories, an Irish-based European CMO, establishes Gaelic Drug Store LLC in Dubai to access the Middle East pharma market.

• The UAE subsidiary enables regulatory compliance and supports marketing, registration, and distribution of pharmaceutical products.

Gaelic Laboratories, a European contract manufacturing organisation (CMO) based in Ireland, has established a new subsidiary, Gaelic Drug Store LLC, in the UAE. This strategic move enables the company to navigate local regulations and meet the growing demand in the Middle East pharmaceutical market, projected to reach $32 billion by 2027.

The company’s new presence in Dubai provides infrastructure for importing, registering, and distributing medicines, including a temperature-controlled warehouse. Additionally, Gaelic Laboratories offers its services as an MAH to partner with international pharma companies seeking regional entry.

“We aim to be a key player in the generic pharma industry while offering contract manufacturing and testing services,” said Brian Morrisey, General Manager. “Now, we are pleased to help other companies register and market their products in the Middle East.”

This expansion builds on Gaelic Laboratories’ EU regulatory expertise, enhanced by its Dubai team of regulatory consultants. The move follows recent regulatory changes requiring companies to have local establishments for product distribution.

Executive Committee Member Mohammed Bazara highlighted the potential, stating, “Our investment in Dubai has been widely recognised internationally. Gaelic Laboratories is ready to help you access the Middle East market.”